Interferon-gamma reduces the proliferation of M. tuberculosis within macrophages from a patient with a novel hypomorphic NEMO mutation

Pediatr Blood Cancer. 2016 Oct;63(10):1863-6. doi: 10.1002/pbc.26098. Epub 2016 Jul 8.

Abstract

X-linked ectodermal dysplasia with immunodeficiency (XL-EDA-ID) is caused by mutations in the nuclear factor-kappa B essential modulator (NEMO) gene. Here, we report the clinical and genetic features of a XL-EDA-ID patient who developed bacillus Calmette-Guérin infection. Patient lymphocytes failed to degrade IκB-α, and sequencing of NEMO identified the novel mutation c.1238A>C/p.H413P. Furthermore, patient monocyte-derived macrophages ingested Mycobacterium tuberculosis normally, but failed to control the intracellular proliferation of bacilli, a defect which was improved in the presence of interferon-gamma (IFN-γ). This work expands the genetic spectrum of XL-EDA-ID and demonstrates improvement in macrophage function in a NEMO-deficient patient by IFN-γ.

Keywords: BCGitis; NEMO; ectodermal dysplasia.

Publication types

  • Case Reports

MeSH terms

  • Ectodermal Dysplasia / drug therapy*
  • Ectodermal Dysplasia / immunology
  • Genetic Diseases, X-Linked / drug therapy*
  • Genetic Diseases, X-Linked / immunology
  • Humans
  • Immunologic Deficiency Syndromes / drug therapy*
  • Immunologic Deficiency Syndromes / immunology
  • Infant
  • Interferon-gamma / pharmacology
  • Interferon-gamma / therapeutic use*
  • Macrophages / microbiology*
  • Male
  • Mycobacterium tuberculosis / drug effects*
  • Primary Immunodeficiency Diseases
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Interferon-gamma

Supplementary concepts

  • NEMO mutation with immunodeficiency